ReviewTropical medicine and health2025
Leveraging a people-centred approach to combat antimicrobial resistance in Africa.
Review in Tropical medicine and health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) poses a severe and growing threat to public health in Africa, disproportionately affecting marginalised and vulnerable populations across communities and health systems. Current responses often prioritise technical measures, such as stewardship programmes and surveillance systems, with insufficient attention to the socioeconomic and cultural realities that drive resistance. AMR cannot be addressed in isolation, as its emergence and spread are closely linked to poverty, inadequate education, gender inequality, poor governance, limited access to healthcare, clean water, sanitation, and diagnostics, as well as weak supply chains for essential medicines. This commentary advocates for a people-centred approach to AMR that addresses the social determinants of health and fosters inclusive, community-driven solutions. Strengthening primary healthcare systems and improving access to affordable, quality-assured antimicrobials and diagnostics must be prioritised to empower both healthcare providers and patients. Local stakeholders are essential for raising awareness, promoting behaviour change, and ensuring cultural relevance through meaningful community engagement. Marginalised populations, including those in underserved regions or disproportionately exposed to infection due to displacement, disability, or comorbidities, should be central to the co-creation of AMR strategies. Embedding AMR initiatives within universal health coverage reforms, expanding preventive measures, such as vaccination, and tackling systemic challenges are also crucial for reducing antibiotic dependence and building equitable health systems. A coordinated, multisectoral response that connects human, animal, and environmental health, grounded in equity, community ownership, and interdisciplinary collaboration, is essential for sustainable AMR control efforts that leave no one behind.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.